Chimerix rises with its bank account

Chimerix Inc. (NASDAQ:CMRX) gained $1.15 to $31.04 after completing its second big follow-on in 2014. The infectious disease company raised $105.9 million through the sale of 3.65 million shares at $29 in a deal underwritten by Morgan Stanley; JP Morgan; Cowen; Piper Jaffray; Stifel, Nicolaus; Cantor Fitzgerald; and Brean Capital.

The company proposed to raise about $105 million after market close on Wednesday when its stock price was $29.79. In May, Chimerix raised $119.4 million through the sale of 8.4 million shares at $14.22. ...